Active Ingredient: LEVETIRACETAM
Proprietary Name: ELEPSIA XR
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 1.5GM
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N204417
Product Number: 002
Approval Date: Dec 20, 2018
Applicant Holder Full Name: TRIPOINT THERAPEUTICS
Marketing Status:
Discontinued
Patent and Exclusivity Information